Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Non-Viral TCR Gene Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
- Status
- COMPLETED
- Phase
- PHASE1
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE1
Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1